Taiwan’s technology sector must play an awkward balancing game amid US-China tensions. This could be a surprisingly favorable position for opportunistic investment and global diversifications
Chinese eye disease specialist Elumninex Biosciences has raised a $50 million Series A round led by GL Ventures, Lilly Asia Ventures (LAV), and Quan Capital.
Anacacia Capital has acquired a controlling stake in Pump Haircare, an Australian organic hair products brand that is looking to further expand its online distribution channels.
Apis Partners has invested $35 million in Indian digital payments services provider Cashfree as part of a Series B round also featuring Smilegate Investment and Y Combinator.
Russia’s DST Global has led a $200 million Series E round for Indian used car platform operator Cars24 at a valuation of more than $1 billion.
Warburg Pincus has agreed to make another partial exit from ESR, the pan-Asian logistics real estate platform it established in 2011 and took public last year, which will see its stake fall to 4.56%.
Manbang Group, China's so-called "Uber for trucks" that matches shippers with drivers and fleet operators, has raised a $1.7 billion round led by SoftBank Vision Fund, Sequoia Capital China, Permira and Fidelity.
Yunyinggu, a Chinese manufacturer of integrated circuits used in flat screen displays, has raised RMB300 million ($46 million) in Series D funding led by Sequoia Capital China.
CDH Investments has reached the first close of RMB1.5 billion ($228 million) on a data center industry fund. Part of the Chinese GP's mezzanine strategy, the vehicle has a full target of RMB2 billion.
Wish, a cross-border e-commerce platform that connects Chinese merchants who primarily sell products through domestic channels like Alibaba Group’s Taobal and Tmall with consumers in the US and Europe, has filed for a US IPO.
500 Startups has launched a Cambodian unit in partnership with Khmer Enterprise, a start-up ecosystem support arm of the local government’s Entrepreneurship Development Fund.
Codemao, a Chinese online education platform that teaches coding to children, has raised RMB1.3 billion ($198 million) in Series D funding led by Baring Private Equity Asia.
Indian conglomerate Reliance Industries has announced the completion of a funding round for its retail unit with INR472.7 billion ($6.4 billion) in commitments from eight investors.
Indian financial technology provider True Balance has raised a $28 million Series D round from a group including SoftBank Ventures Asia.
Antengene, a China-based drug developer that previously raised $238 million across three private funding rounds, closed roughly flat on its first day of trading in Hong Kong following a HK$2.78 billion ($359 million) IPO.
Going on the offensive is the best response to COVID-19 - taking advantage of market uncertainty to make new investments and help portfolio companies complete bolt-on acquisitions - the AVCJ Forum heard.
PingCap, a China cloud database service provider, has raised a $270 million Series D round led by GGV Capital, Access Technology Venture, Anatole Investment, Jeneration Capital and 5Y Capital.
Yatsen Holding, the parent company of Chinese cosmetics brand Perfect Diary, gained 75% on its first day of trading on the New York Stock Exchange following a $616.9 million IPO.
Macquarie and Armitage Associates are both set to make partial exits when analytics software provider Nuix completes its Australia IPO.
Warburg Pincus and Advantage Partners triumphed in the firm of the year categories at the 2020 AVCJ Private Equity & Venture Capital Awards, with The Carlyle Group and Affinity Equity Partners also among the winners with two trophies apiece.
D3 Bio, a Chinese drug developer that studies and specifically targets areas where existing approaches to care are not delivering satisfactory outcomes, has raised $200 million in Series A funding.
KKR has acquired Argenta, a New Zealand-based animal health services provider, for an undisclosed sum.
North American and European LPs see promise in Asia, and China in particular, but remain wary due to a lack of control opportunities, especially in the context of COVID-19.